Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125378911 | 12537891 | 1 | I | 20160413 | 20160622 | 20160707 | 20160707 | EXP | TO20161297 | FR-VALIDUS PHARMACEUTICALS LLC-FR-2016VAL002229 | VALIDUS | 86.00 | YR | F | Y | 0.00000 | 20160707 | OT | FR | FR |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125378911 | 12537891 | 1 | PS | FUROSEMIDE. | FUROSEMIDE | 1 | Oral | 40 MG, BID | 160 | MG | N | 16273 | 40 | MG | TABLET | ||||
| 125378911 | 12537891 | 2 | SS | PANTOPRAZOLE | PANTOPRAZOLE SODIUM | 1 | Intravenous (not otherwise specified) | 40 MG, QD | 360 | MG | N | 0 | 40 | MG | POWDER FOR SOLUTION FOR INJECTION | ||||
| 125378911 | 12537891 | 3 | SS | MIDAZOLAM | MIDAZOLAMMIDAZOLAM HYDROCHLORIDE | 1 | Intravenous (not otherwise specified) | 30 MG, QD | 90 | MG | N | 0 | 30 | MG | |||||
| 125378911 | 12537891 | 4 | SS | PIPERACILLIN | PIPERACILLIN | 1 | Oral | 4 G, TID | 96 | G | N | 0 | 4 | G | |||||
| 125378911 | 12537891 | 5 | SS | TAZOBACTAM | TAZOBACTAM | 1 | Oral | 500 MG, TID | 12000 | MG | N | 0 | 500 | MG | |||||
| 125378911 | 12537891 | 6 | SS | OXYNORMORO | OXYCODONE | 1 | Oral | 5 MG, QD | 35 | MG | N | 0 | 5 | MG | TABLET | ||||
| 125378911 | 12537891 | 7 | SS | SERESTA | OXAZEPAM | 1 | Oral | 10 MG, QD | 70 | MG | N | 0 | 10 | MG | TABLET | ||||
| 125378911 | 12537891 | 8 | C | CAELYX | DOXORUBICIN HYDROCHLORIDE | 1 | UNK | 0 | |||||||||||
| 125378911 | 12537891 | 9 | C | CALCIPARINE | HEPARIN CALCIUM | 1 | UNK | N | 0 | ||||||||||
| 125378911 | 12537891 | 10 | C | DOLIPRANE | ACETAMINOPHEN | 1 | UNK | N | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 125378911 | 12537891 | 1 | Product used for unknown indication |
| 125378911 | 12537891 | 2 | Product used for unknown indication |
| 125378911 | 12537891 | 3 | Product used for unknown indication |
| 125378911 | 12537891 | 4 | Product used for unknown indication |
| 125378911 | 12537891 | 5 | Product used for unknown indication |
| 125378911 | 12537891 | 6 | Product used for unknown indication |
| 125378911 | 12537891 | 7 | Product used for unknown indication |
| 125378911 | 12537891 | 8 | Product used for unknown indication |
| 125378911 | 12537891 | 9 | Product used for unknown indication |
| 125378911 | 12537891 | 10 | Product used for unknown indication |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 125378911 | 12537891 | HO |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 125378911 | 12537891 | Acute kidney injury | |
| 125378911 | 12537891 | Anuria | |
| 125378911 | 12537891 | Haematuria | |
| 125378911 | 12537891 | Proteinuria |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 125378911 | 12537891 | 1 | 20160412 | 20160416 | 0 | |
| 125378911 | 12537891 | 2 | 20160405 | 20160414 | 0 | |
| 125378911 | 12537891 | 3 | 20160411 | 20160416 | 0 | |
| 125378911 | 12537891 | 4 | 20160406 | 20160413 | 0 | |
| 125378911 | 12537891 | 5 | 20160406 | 20160413 | 0 | |
| 125378911 | 12537891 | 6 | 20160407 | 20160416 | 0 | |
| 125378911 | 12537891 | 7 | 20160407 | 20160416 | 0 | |
| 125378911 | 12537891 | 8 | 20160307 | 0 | ||
| 125378911 | 12537891 | 9 | 20160331 | 20160416 | 0 | |
| 125378911 | 12537891 | 10 | 20160412 | 20160416 | 0 |